Dr. Swetha Kadali, MD

Dr. Kadali practices at Internal Medicine Associates of Plano PA in Frisco, Texas.

Dr. Kadali's NPI, 1902210875, was assigned on June 18, 2014. Dr. Kadali graduated from Kamineni Institute of Medical Science in 2011. Dr. Kadali's Arkansas license number on file is E-10771.

Dr. Kadali's primary practice is Internal Medicine Associates of Plano PA, at 255 W Lebanon Rd, Frisco, TX 75036 in Denton County. The practice phone is (972) 981-7500.

Dr. Kadali's primary practice is Internal Medicine Associates of Plano PA in Frisco, Texas. The medical group on file is Internal Medicine Associates of Plano. Dmand AI also links Dr. Kadali to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kadali practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Kadali's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kadali is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kadali's licenses on file in 2 states: Arkansas and Texas.

Dmand AI lists acid reflux, atrial fibrillation and flutter, chronic anemia, chronic diabetes, chronic hypertension, chronic kidney disease, chronic nasal allergies and chronic respiratory failure among the conditions Dr. Kadali treats.

CMS data shows 2,313 Medicare services from Dr. Kadali across 28 procedure codes in 2024, for 111 Medicare patients. Medicare paid $71,185 for them. Every service was in an office.

CMS counts 111 Medicare patients who saw Dr. Kadali in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kadali's median patient age at 57, with 71% women.

In 2024, Dr. Kadali wrote 1,905 Medicare Part D claims for 181 patients. 86% of them were for generic drugs. CMS names the drug for 1,434 of them, across 38 drugs with 11 or more claims each, at $104,585 in total drug cost. In 2023, CMS named 1,088 claims across 32 drugs.

Dr. Kadali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kadali as offering telehealth.

CMS Open Payments shows 81 general payments to Dr. Kadali from 27 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 96% of the total. Abbott Laboratories paid the most, $271.

Dr. Kadali graduated from Kamineni Institute of Medical Science in 2011.

Dr. Kadali is in network with 20 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.